**Core Concept**
Cardiac hypertrophy is a condition characterized by thickening of the heart muscle (myocardium) in response to increased workload, often due to high blood pressure, heart valve problems, or other conditions. This process involves complex molecular mechanisms that regulate gene expression, cellular growth, and adaptation.

**Why the Correct Answer is Right**
The key factor responsible for cardiac hypertrophy is the activation of the calcineurin-NFAT (nuclear factor of activated T-cells) signaling pathway. This pathway is triggered by the increased activity of mechanoreceptors in the heart, which sense the increased pressure and stretch. The mechanoreceptors activate the G-protein coupled receptor, which in turn activates the phospholipase C (PLC) pathway. This leads to the production of inositol trisphosphate (IP3) and diacylglycerol (DAG), which increase intracellular calcium levels. Elevated calcium levels activate calcineurin, a calcium/calmodulin-dependent phosphatase, which dephosphorylates and activates NFAT. NFAT then translocates to the nucleus, where it binds to specific DNA sequences and regulates the expression of genes involved in cardiac hypertrophy.

**Why Each Wrong Option is Incorrect**
* **Option A:** This option is not specified, but we will assume it is a distractor. If we were to choose a distractor, it might be a factor that is not directly linked to cardiac hypertrophy, such as a hormone or growth factor.
* **Option B:** Angiotensin II is a vasoconstrictor that plays a role in regulating blood pressure, but it is not the primary factor responsible for cardiac hypertrophy.
* **Option C:** This option is not specified, but we will assume it is a distractor. If we were to choose a distractor, it might be a factor that is not directly linked to cardiac hypertrophy, such as a metabolic pathway or a cellular process.

**Clinical Pearl / High-Yield Fact**
The calcineurin-NFAT pathway is a key regulator of cardiac hypertrophy, and its activation is a critical step in the development of heart failure. Understanding this pathway is essential for developing targeted therapies for the treatment of cardiac hypertrophy and heart failure.

**Correct Answer:** C.